CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 52 filers reported holding CASI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,479,000 | -19.5% | 3,061,331 | -20.5% | 0.00% | – |
| Q4 2021 | $3,080,000 | -34.0% | 3,851,090 | -1.8% | 0.00% | – |
| Q3 2021 | $4,665,000 | -22.9% | 3,919,930 | +0.4% | 0.00% | – |
| Q2 2021 | $6,053,000 | -40.3% | 3,904,627 | -7.6% | 0.00% | – |
| Q1 2021 | $10,137,000 | +3.7% | 4,223,694 | +27.4% | 0.00% | – |
| Q4 2020 | $9,777,000 | +119.9% | 3,314,362 | +14.1% | 0.00% | – |
| Q3 2020 | $4,446,000 | -30.1% | 2,905,518 | +14.1% | 0.00% | – |
| Q2 2020 | $6,364,000 | +30.8% | 2,545,942 | +6.7% | 0.00% | – |
| Q1 2020 | $4,866,000 | -32.6% | 2,385,836 | +2.2% | 0.00% | – |
| Q4 2019 | $7,217,000 | -7.6% | 2,335,486 | -0.2% | 0.00% | – |
| Q3 2019 | $7,814,000 | +4.6% | 2,339,543 | +0.3% | 0.00% | – |
| Q2 2019 | $7,468,000 | +11.6% | 2,333,590 | +0.1% | 0.00% | – |
| Q1 2019 | $6,691,000 | -24.8% | 2,331,167 | +5.3% | 0.00% | – |
| Q4 2018 | $8,902,000 | -1.4% | 2,214,529 | +14.6% | 0.00% | – |
| Q3 2018 | $9,027,000 | -37.5% | 1,933,143 | +10.2% | 0.00% | -100.0% |
| Q2 2018 | $14,441,000 | +169.4% | 1,754,681 | +36.5% | 0.00% | – |
| Q1 2018 | $5,360,000 | +76.2% | 1,285,475 | +37.3% | 0.00% | – |
| Q4 2017 | $3,042,000 | +378.3% | 936,186 | +160.8% | 0.00% | – |
| Q3 2017 | $636,000 | +110.6% | 358,972 | +24.7% | 0.00% | – |
| Q2 2017 | $302,000 | -38.5% | 287,890 | -16.8% | 0.00% | – |
| Q1 2017 | $491,000 | +23.4% | 346,177 | 0.0% | 0.00% | – |
| Q4 2016 | $398,000 | -2.2% | 346,177 | -5.6% | 0.00% | – |
| Q3 2016 | $407,000 | -9.2% | 366,642 | -4.2% | 0.00% | – |
| Q2 2016 | $448,000 | +10.3% | 382,798 | 0.0% | 0.00% | – |
| Q1 2016 | $406,000 | +10.3% | 382,798 | +0.0% | 0.00% | – |
| Q4 2015 | $368,000 | -99.8% | 382,698 | -92.8% | 0.00% | -100.0% |
| Q3 2015 | $168,086,000 | +23084.3% | 5,317,788 | +1212.8% | 0.01% | – |
| Q2 2015 | $725,000 | +23.3% | 405,060 | +1.2% | 0.00% | – |
| Q1 2015 | $588,000 | +10.5% | 400,060 | 0.0% | 0.00% | – |
| Q4 2014 | $532,000 | -25.7% | 400,060 | 0.0% | 0.00% | – |
| Q3 2014 | $716,000 | +1.6% | 400,060 | +2.1% | 0.00% | – |
| Q2 2014 | $705,000 | – | 391,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |